Alcon Inc. (ALC)
- Previous Close
78.84 - Open
78.32 - Bid 78.29 x 1000
- Ask 90.00 x 1100
- Day's Range
78.30 - 79.00 - 52 Week Range
69.44 - 88.23 - Volume
1,113,874 - Avg. Volume
919,642 - Market Cap (intraday)
38.853B - Beta (5Y Monthly) 0.67
- PE Ratio (TTM)
40.19 - EPS (TTM)
1.96 - Earnings Date --
- Forward Dividend & Yield 0.27 (0.35%)
- Ex-Dividend Date May 10, 2024
- 1y Target Est
91.68
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
www.alcon.com25,315
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ALC
Performance Overview: ALC
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALC
Valuation Measures
Market Cap
38.83B
Enterprise Value
42.86B
Trailing P/E
40.19
Forward P/E
25.58
PEG Ratio (5yr expected)
4.41
Price/Sales (ttm)
4.14
Price/Book (mrq)
1.88
Enterprise Value/Revenue
4.53
Enterprise Value/EBITDA
19.12
Financial Highlights
Profitability and Income Statement
Profit Margin
10.30%
Return on Assets (ttm)
2.17%
Return on Equity (ttm)
4.83%
Revenue (ttm)
9.45B
Net Income Avi to Common (ttm)
974M
Diluted EPS (ttm)
1.96
Balance Sheet and Cash Flow
Total Cash (mrq)
1.1B
Total Debt/Equity (mrq)
24.95%
Levered Free Cash Flow (ttm)
416.62M
Research Analysis: ALC
Company Insights: ALC
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: ALC
Analyst Report: Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
RatingPrice TargetEconomic Growth Amid Slowing Inflation Confounds the Experts
The Portfolio Selector features the Argus Focus List, a group of 30 "best idea" stocks generated and regularly updated by Argus' analysts and investment policy committee. It also includes the director of research’s monthly investment strategy column, stock recommendations and sector picks, economic forecasts, and an asset allocation model. This month, the Focus List additions are Capital One Financial Corp. (COF); Dominos Pizza Inc (DPZ); Novo Nordisk (NVO); Shell Plc (SHEL) and the Focus List deletions are Alcon Inc. (ALC); Expedia Group Inc (EXPE); Morgan Stanley (MS); Exxon Mobil Corp. (XOM).
Market Digest: M, NTAP, NYT, BCE, RHHBY, BHF, UBER, ALC, VTRS
March 4, 2024 Monday Tee Up: Jobs, Powell, COST
Analyst Report: Alcon Inc.
Alcon Inc. is a global provider of ophthalmic surgery and vision care products. Founded in 1945 and based in Switzerland, Alcon previously operated as a subsidiary of Novartis AG. It became an independent company on April 9, 2019. The company has more than 25,300 employees.
RatingPrice Target